How a real-world evidence database wants to make big data usable for medicine

Real-world evidence is revolutionizing drug approval

XO Life (formerly Medikura Digital Health GmbH) based in Munich is driving innovation in pharmaceutical research with its digital real-world evidence database. The developed platform enables a quick, user-friendly and comprehensive assessment of the risk/benefit ratio of new drugs by collecting and analyzing data directly from real care practice. By sharing their experiences with drugs in a standardized way and in compliance with data protection regulations, MEDIKURA provides important insights into the effectiveness and safety of therapies. This information is critical to overcome the limitations of traditional randomized controlled trials (RCTs), particularly when treating rare diseases or recording long-term effects. The platform is an indispensable resource for doctors, pharmacists and research companies and makes a significant contribution to precision medicine by supporting the development of targeted treatments.